Search
SOLACI Congress
Highlighted PresentationsStructural heart diseaseValvular Aortic valve

SOLACI-SBHCI 2023 | TAVR – Lifetime Management of Patients with Aortic Stenosis – Dr. Ole de Backer

solaci
solaci
483
0

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress.

In this case, check the presentation by Dr. Ole de Backer, entitled “TAVR – Lifetime Management of Patients with Aortic Stenosis”

Ole-de-backer-copacabana-room-lifetime-management-solaci-sbhci-2023

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-SBHCI 2023 | Insights from the LATAM Peripheral Registry – Dr. Maximiliano Rossi
Next article
SOLACI-SBHCI 2023 | TAVI – Minimizing Risks, Optimizing Outcomes & Impact of the Index Procedure on Future Options – Dr. Ole De Backer
solaci
solaci

More articles by this author

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 0
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Dr. Omar Tupayachi - 0
Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Mitral valve

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated...
Dr. Andrés Rodríguez -
SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 0
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Dr. Juan Manuel Pérez - 0
Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 0
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Dr. Juan Manuel Pérez - 0
Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Institutional News

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

solaci - 0
Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

SOLACI Session at Miami Valves 2026

solaci - 0
Once again, the Latin American Society of Interventional Cardiology will be present at one of the most important congresses worldwide in the field, with...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy